189 related articles for article (PubMed ID: 15924763)
21. Safe administration of high-dose methotrexate with minimal drug level monitoring: Experience from a center in north India.
Dhingra H; Kalra M; Mahajan A
Pediatr Blood Cancer; 2020 Nov; 67(11):e28394. PubMed ID: 32813334
[TBL] [Abstract][Full Text] [Related]
22. [Cerebrospinal fluid methotrexate level in children treated with medium-high and high doses of the drug].
Wysocki M; Balcar-Boroń A; Krzyzanowski M; Szadujkis-Szadurski L; Ozyński T; Nowaczyk-Michalak A
Acta Haematol Pol; 1992; 23(3):185-90. PubMed ID: 1492543
[TBL] [Abstract][Full Text] [Related]
23. Patient characteristics associated with high-risk methotrexate concentrations and toxicity.
Relling MV; Fairclough D; Ayers D; Crom WR; Rodman JH; Pui CH; Evans WE
J Clin Oncol; 1994 Aug; 12(8):1667-72. PubMed ID: 8040679
[TBL] [Abstract][Full Text] [Related]
24. How long can folinic acid rescue be delayed after high-dose methotrexate without toxicity?
Cohen IJ; Wolff JE
Pediatr Blood Cancer; 2014 Jan; 61(1):7-10. PubMed ID: 24038885
[TBL] [Abstract][Full Text] [Related]
25. [Serial spectral EEG analysis in children treated with intermediate-dose methotrexate (ID-MTX)].
Fujii Y; Hongo T; Igarashi Y
Rinsho Ketsueki; 1988 Nov; 29(11):2062-7. PubMed ID: 3236413
[No Abstract] [Full Text] [Related]
26. Acral erythema with oral methotrexate in a child.
Varela CR; McNamara J; Antaya RJ
Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
[TBL] [Abstract][Full Text] [Related]
27. Repeated Episodes of Leukoencephalopathy after High-dose Methotrexate in a Child with Acute Lymphoblastic Leukemia.
Tsao TF; Chao YH
Indian Pediatr; 2017 Feb; 54(2):159. PubMed ID: 28285295
[No Abstract] [Full Text] [Related]
28. Occurrence and impact of unanticipated variation in intravenous methotrexate dosing.
Parshuram CS; Dupuis LL; To T; Weitzman SS; Koren G; Laupacis A
Ann Pharmacother; 2006 May; 40(5):805-11. PubMed ID: 16638922
[TBL] [Abstract][Full Text] [Related]
29. Transient encephalopathy following high-dose methotrexate.
Lee AC; Li CH; Wong YC
Med Pediatr Oncol; 2003 Jul; 41(1):101. PubMed ID: 12764767
[No Abstract] [Full Text] [Related]
30. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
[TBL] [Abstract][Full Text] [Related]
31. Brief report: effect of intravenous methotrexate dose and infusion rate on neuropsychological function one year after diagnosis of acute lymphoblastic leukemia.
Carey ME; Hockenberry MJ; Moore IM; Hutter JJ; Krull KR; Pasvogel A; Kaemingk KL
J Pediatr Psychol; 2007 Mar; 32(2):189-93. PubMed ID: 16675716
[TBL] [Abstract][Full Text] [Related]
32. Intrathecal methotrexate-induced acute chorea.
Necioğlu Orken D; Yldrmak Y; Kenangil G; Kandraloğlu N; Forta H; Celik M
J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
[TBL] [Abstract][Full Text] [Related]
33. [Assessment of elimination and tolerance of high dose of methotrexate (3 g/m2) in children with standard-risk acute lymphoblastic leukemia].
Cwliklińska M; Balwierz W; Nowak J; Stanuch H
Przegl Lek; 2006; 63(1):15-20. PubMed ID: 16892893
[TBL] [Abstract][Full Text] [Related]
34. Does vitamin A prevent high-dose-methotrexate-induced D-xylose malabsorption in children with cancer?
Dagdemir A; Yildirim H; Aliyazicioglu Y; Kanber Y; Albayrak D; Acar S
Support Care Cancer; 2004 Apr; 12(4):263-7. PubMed ID: 14767751
[TBL] [Abstract][Full Text] [Related]
35. Retrospective study on elimination delay of methotrexate in high-dose therapy of childhood acute lymphoblastic leukemia in China.
Xu W; Tang Y; Song H; Shi S; Yang S
J Pediatr Hematol Oncol; 2007 Oct; 29(10):688-93. PubMed ID: 17921849
[TBL] [Abstract][Full Text] [Related]
36. [Investigation on individualized adjustment of target range of high-dose methotrexate].
Hua Y; Zhao WH; Lu XT; Yang LH; Lu W
Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of folinic acid in children with acute lymphoblastic leukemia.
Borsi JD; Sagen E; Romslo I; Moe PJ
Haematol Blood Transfus; 1990; 33():118-21. PubMed ID: 2323623
[No Abstract] [Full Text] [Related]
38. High dose methotrexate treatment in children with acute lymphoblastic leukaemia may be optimised by a weight-based dose calculation.
Jönsson P; Skärby T; Heldrup J; Schrøder H; Höglund P
Pediatr Blood Cancer; 2011 Jul; 57(1):41-6. PubMed ID: 21425443
[TBL] [Abstract][Full Text] [Related]
39. High-dose methotrexate in childhood all.
Moe PJ; Holen A
Pediatr Hematol Oncol; 2000 Dec; 17(8):615-22. PubMed ID: 11127393
[TBL] [Abstract][Full Text] [Related]
40. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
Mahadeo KM; Santizo R; Baker L; Curry JO; Gorlick R; Levy AS
Pediatr Blood Cancer; 2010 Dec; 55(7):1296-9. PubMed ID: 20949591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
